We have shown that endogenous TIMP‐3 knockdown reverses the inhibitory effect of mAb NJ001 on cancer cell invasiveness, which indicates thatTIMP‐3 is a key regulator of the antimetastatic function of mAb NJ001. The gene discussed is TIMP3; the disease is cancer.